Neurogene Inc. NGNE
Regular-session close
After hours · Nov 19, 5:15 PM ET
- YTD
- +11.31%
- 1 year
- +9.24%
Held by funds
73 US ETFs and mutual funds hold NGNE · largest positions
- VTI 0.00% of fund $11.31M
- IWM 0.01% of fund $9.59M
- NJM 0.01% of fund $6.99M
- XBI 0.07% of fund $6.31M
- FBTTX 0.21% of fund $4.93M
- VXF 0.01% of fund $4.87M
- FSSNX 0.01% of fund $4.49M
- IWN 0.03% of fund $3.51M
- IBB 0.03% of fund $2.89M
- FESM 0.04% of fund $2.64M
- VTWO 0.01% of fund $2.55M
- NAJ 0.02% of fund $2.51M
- FSMAX 0.01% of fund $2.02M
- FBIOX 0.02% of fund $1.42M
- IWC 0.10% of fund $1.11M
- VFMO 0.05% of fund $981.49K
- FSKAX 0.00% of fund $914.19K
- VHT 0.00% of fund $873.36K
- MDSKX 0.01% of fund $796.88K
- IJE 0.05% of fund $772.52K
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.24% | 1,371,879 | 30.87M | Sep 29, 2024 |
| EcoR1 Capital, LLC | 8.56% | 1,271,342 | 28.61M | Sep 29, 2024 |
| Samsara BioCapital, LLC | 8.53% | 1,267,790 | 28.53M | Sep 29, 2024 |
| RTW Investments LP | 7.64% | 1,135,256 | 25.54M | Sep 29, 2024 |
| Great Point Partners LLC | 6.76% | 1,004,291 | 22.60M | Sep 29, 2024 |
| Redmile Group, LLC | 6.49% | 964,347 | 21.70M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.26% | 335,977 | 7.56M | Sep 29, 2024 |
| BlackRock Health Sciences Term Trust | 2.20% | 326,877 | 7.35M | Sep 29, 2024 |
| Fidelity Small Cap Growth Fund | 1.94% | 288,922 | 6.50M | Aug 30, 2024 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 1.91% | 284,041 | 6.39M | Aug 30, 2024 |
| Janus Henderson Global Life Sciences Fund | 1.87% | 278,165 | 6.26M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.79% | 265,755 | 5.98M | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs NGNE, and what each was last paid
Rachel L. McMinn, Founder, Executive Chair & Chief Executive OfficerAverage age 52
| Name | Title | Pay | Age |
|---|---|---|---|
| Rachel L. McMinn | Founder, Executive Chair & Chief Executive Officer | $997K | 53 |
| Christine Mikail Cvijic | President, CFO & Director | $874K | 48 |
| Julie Jordan | Chief Medical Officer | $696K | 54 |
| Stuart Cobb | Chief Scientific Officer | $479K | 55 |
| Andrew E. Mulberg FAAP | Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control | — | — |
| Arvind Sreedharan | Senior Vice President of Business Operations | — | — |
| Ricardo Jimenez | Senior Vice President of Technical Operations | — | — |
| Christina Shafer | Chief Commercial Officer | — | 50 |
| Donna Cochener-Metcalfe | Senior Vice President, General Counsel & Corporate Secretary | — | 51 |
| Lina Li | Executive Director of Investor Relations | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKER BROS ADVISORS L.P. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Oct 4, 2023 | 0 |
| COBB STUART | Officer | Stock Award(Grant) | Mar 12, 2024 | 20,391 |
| CVIJIC CHRISTINE MIKAIL | President | Purchase | Nov 21, 2024 | 76,844 |
| MCMINN RACHEL L. PH.D. | Chief Executive Officer | Purchase | Nov 21, 2024 | 1,297,860 |
| PATEL PRITI | Former | Sale | Apr 2, 2023 | 37,313 |
| SAMSARA BIOCAPITAL GP, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Nov 25, 2024 | 0 |
